Guggenheim Cuts Zevra Therapeutics (NASDAQ:ZVRA) Price Target to $23.00

Дата публикации: 10-08-2026 05:48:47

Zevra Therapeutics (NASDAQ:ZVRA – Free Report) had its price target decreased by Guggenheim from $24.00 to $23.00 in a report released on Friday,Benzinga reports. Guggenheim currently has a buy rating on the stock. ZVRA has been the topic of a number of other research reports. Maxim Group upped their target price on Zevra Therapeutics from […]

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Guggenheim Cuts First Watch Restaurant Group (NASDAQ:FWRG) Price Target to $20.00	0	10.81	10-08-2026
2	Keefe, Bruyette & Woods Cuts Zillow Group (NASDAQ:Z) Price Target to $34.00	0	12.61	10-08-2026
3	Genmab A/S (NASDAQ:GMAB) Price Target Raised to $42.00	0	9.76	10-08-2026
4	Roivant Sciences (NASDAQ:ROIV) Price Target Raised to $42.00	0	11.84	10-08-2026
5	UBS Group Cuts Zoetis (NYSE:ZTS) Price Target to $80.00	0	10.45	10-08-2026
6	Needham & Company LLC Cuts TechTarget (NASDAQ:TTGT) Price Target to $8.00	0	13	10-08-2026
7	BTIG Research Cuts NRx Pharmaceuticals (NASDAQ:NRXP) Price Target to $10.00	0	9.08	10-08-2026
8	Piper Sandler Cuts Papa John’s International (NASDAQ:PZZA) Price Target to $26.00	0	11.89	10-08-2026
9	Rosenblatt Securities Cuts Trade Desk (NASDAQ:TTD) Price Target to $12.00	0	11.14	10-08-2026
10	Sezzle (NASDAQ:SEZL) Price Target Raised to $172.00	0	11.53	10-08-2026

Классификация: Экономика. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 9.15. Источник: www.americanbankingnews.com.